IDEXX Laboratories, Inc. (NASDAQ: IDXX) will launch incomes outcomes for the 3rd quarter, before the opening bell on Monday, Nov. 3.
Experts anticipate the Westbrook, Maine-based business to report quarterly incomes at $3.14 per share, up from $2.80 per share in the year-ago duration. The agreement quote for IDEXX Laboratories’ quarterly profits is $1.07 billion, compared to $975.54 million a year previously, according to information from Benzinga Pro.
On Aug. 4, IDEXX Laboratories reported better-than-expected second-quarter monetary outcomes and raised its FY25 assistance above quotes.
Shares of IDEXX Laboratories increased 0.2% to close at $629.51 on Friday.
Benzinga readers can access the most recent expert rankings on the Expert Stock Scores page. Readers can arrange by stock ticker, business name, expert company, ranking modification or other variables.
Let’s take a look at how Benzinga’s most-accurate experts have actually ranked the business in the current duration.
- Stifel expert Jonathan Block updated the stock from Hold to Purchase and raised the cost target from $640 to $700 on Oct. 31, 2025. This expert has a precision rate of 72%.
- UBS expert Andrea Alfonso started protection on the stock with a Neutral ranking and a rate target of $720 on Oct. 1, 2025. This expert has a precision rate of 78%.
- Morgan Stanley expert Erin Wright kept an Obese ranking and increased the cost target from $722 to $765 on Aug. 15, 2025. This expert has a precision rate of 73%.
- Piper Sandler expert David Westenberg kept a Neutral ranking and increased the cost target from $510 to $700 on Aug. 11, 2025. This expert has a precision rate of 73%.
- JP Morgan expert Chris Scott kept an Obese ranking and raised the cost target from $550 to $675 on Aug. 4, 2025. This expert has a precision rate of 62%
Thinking about purchasing IDXX stock? Here’s what experts believe:
Read This Next:
Image through Shutterstock
Market News and Data gave you by Benzinga APIs